Skip to content
  1. Home/
  2. Latest news/
  3. Johnson & Johnson makes Fortune‘s 2017 Change the World list
A photo of Alex Gorsky and Pat Gorksy with mMitra families in India
Alex Gorsky, Chairman and CEO of Johnson & Johnson, and his wife, Pat Gorsky, visit families who’ve benefited from mMitra Johnson & Johnson

Johnson & Johnson makes Fortune‘s 2017 Change the World list

The company nabs the #9 spot this year for helping to decrease mother and baby mortality rates in India through the mMitra program.

Alex Gorsky, Chairman and CEO of Johnson & Johnson, and his wife, Pat Gorsky, visit families who’ve benefited from mMitra Johnson & Johnson

For the second year in a row, Johnson & Johnson has been nominated to the annual Fortune Change the World list, which spotlights 50 top companies globally that have had a “positive social impact through activities that are part of their core business strategy.”

Johnson & Johnson was recognized for its work with mMitra, an innovative mobile-messaging program that sends vital health information to expectant and new mothers living in low-income urban communities in India.

The company ranks #9 on the list this year—up over 20 spots from its #31 ranking on the 2016 list for its work to help combat tuberculosis.

This latest recognition for Johnson & Johnson comes on the heels of being named a Most Admired Company by Fortune in February, underscoring its reputation as one of the best companies to work for.

How mMitra is making a difference

Johnson & Johnson spearheaded mMitra (short for “mobile friend” in Hindi) in 2014, in partnership with the Mobile Alliance for Maternal Action, ARMMAN, the U.S. Agency for International Development, the United Nations Foundation and BabyCenter®.

Their shared goal: help the roughly 150 mothers and 3,500 children under the age of 5 who die each day in India from pregnancy complications or early childhood disease. Such grim statistics are due, in part, to a lack of accessibility to basic health information.

A study conducted by the Foundation for Research in Health Systems on the communities using mMitra showed an increase in antenatal visits and baby immunization rates, as well as earlier registrations of pregnancies.

Since most women throughout India have access to a mobile phone, the thinking with mMitra was that women could get free calls and texts in their dialect providing expert health and preventative care information tailored to a mom’s stage of pregnancy or a child’s development.

“There were limited models of this type of program, and definitely none at scale,” says Alice Lin Fabiano, Johnson & Johnson’s Director of Global Community Impact. “We were the first in the private sector to do something like this in multiple global locations specifically targeting low-income families.”

The results are certainly heartening.

More than 1 million mothers in India have since participated, and an independent study conducted by the Foundation for Research in Health Systems on the communities using mMitra showed an increase in antenatal visits and baby immunization rates, as well as earlier registrations of pregnancies.

And there’s even more planned for mMitra, which is now available in more than 10 countries, including South Africa, Malawi and Mexico.

“We’re now looking at technology beyond voice and text,” Fabiano says. “Videos and visuals will increase the effectiveness of the message and the sustainability of the program.”

More from Johnson & Johnson

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.

Using your own cells to fight cancer

Cell therapy is bringing the world one step closer to eliminating cancer. Here’s how Johnson & Johnson is moving this cutting-edge therapy forward.